General News

AstraZeneca halts COVID-19-vaccine trial

AstraZeneca halts COVID-19-vaccine trial

Drug giant AstraZeneca has put its coronavirus-vaccine testing on hold after a study participant suffered a possible serious side effect, a report said Tuesday.

The pharmaceutical manufacturer has been testing a potential vaccine it developed with the University of Oxford in Britain, and a UK participant’s suspected negative reaction to it prompted what the company called a “routine” temporary halt to its program, said the health website Stat News, which is tied to the Boston Globe.

“This is a routine action which has to happen whenever there is a potentially unexplained illness in one of the trials, while it is investigated, ensuring we maintain the integrity of the trials,” AstraZeneca said in a statement.

“In large trials, illnesses will happen by chance but must be independently reviewed to check this carefully.”

mm

Devon is a fitness enthusiast who loves playing Golf in his free time. He keeps in touch with the Golf events happening all around the world and jots down fine news pieces for the website.

About the author

mm

Devon Bell

Devon is a fitness enthusiast who loves playing Golf in his free time. He keeps in touch with the Golf events happening all around the world and jots down fine news pieces for the website.

Add Comment

Click here to post a comment

Your email address will not be published. Required fields are marked *